Elafibranor Pharmacokinetic Parameters in Hepatic Impaired Patients

Clinical trial NCT03765671 · COMPLETED

Trial details

NCT number: NCT03765671
Sponsor: Genfit
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatic Impairment Liver Disease Pharmacokinetics

Start date: 2018-12-12
Primary completion: 2019-06-07
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.